Attached files
| file | filename |
|---|---|
| 8-K - 8-K - Bausch Health Companies Inc. | d574700d8k.htm |
| EX-99.1 - EX-99.1 - Bausch Health Companies Inc. | d574700dex991.htm |
 Valeant Organization
J. Michael Pearson
Chairman & CEO
Howard Schiller
Chief Financial Officer
Rob Chai-Onn
General Counsel
Ryan Weldon
Company Group
Chairman
Brian Stolz
Chief Human
Capital Officer &
Administration
Laizer Kornwasser
Company Group
Chairman
•
Tom Appio
North Asia
•
Tanya Carro
Corporate Controller
•
Andrew Howden
Australia, Southeast
Asia, India, S. Africa
•
Jerry Janeczko
Information Technology
•
Linda LaGorga
Treasurer
•
Jeremy Lipshy
Tax
•
Andrew Davis
Corporate Development
•
Dennis Asharin
Supply Chain &
Procurement
•
Open
Customer Service
•
Jacques Dessureault
Canada
•
Robert Polans
Managed Markets
•
Steve Sembler
OraPharma, Neuro &
Other
•
Asha Soto
Trade Relations
Seana Carson
Chief Compliance
Officer
Dan Wechsler
Company Group
Chairman
Tage Ramakrishna
Chief Medical
Officer
Pavel Mirovsky
President & GM
EMEA
•
Dennis Asharin
Manufacturing
•
Marcelo Barboza
Brazil & Argentina
•
Open
Sales & Marketing
Surgical Equipment
•
Richard D’Souza
R&D, Eye Care
•
Craig Dashefsky
Commercial Ops
•
Philip Gioia
Generics
•
Joe Gordon
Consumer
•
Calvin Roberts
CMO, Eye Care
•
Javier Rovalo
Mexico
•
Hemanth Varghese
Vision Care
•
Open
Sales & Marketing
Pharma
•
Open
Sales & Marketing
Surgical Lenses
•
Charles Hahn
Professional Relations
•
Vincent Ippolito
Aesthetics
•
Craig Dashefsky
Commercial Operations
•
Deborah Jorn
Marketing, Dermatology
•
Robert Polans
Sales, Dermatology
•
Tage Ramakrishna
R&D, Dermatology
Neuro and Other
•
Preston Romm
Obagi
•
John Connolly
Region 2
•
Christos Kartalis
Region 3
•
Open
Region 4
•
Leszek Wojtowicz
Region 1
NOTE -
Rod Unsworth, Mike Gowen, and Sue Hall have
agreed to stay on for the transition.
Laurie Little
Investor Relations
Exhibit 99.2 |